|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's range||122.50 - 124.67|
|52-week range||62.91 - 134.39|
|Beta (5Y monthly)||1.30|
|PE ratio (TTM)||46.94|
|Earnings date||28 Oct 2020|
|Forward dividend & yield||0.28 (0.23%)|
|Ex-dividend date||15 Oct 2020|
|1y target est||128.86|
Covid-19 News: The NIH's NCATS division is using PerkinElmer's AlphaLISA immunoassay to screen compounds for potential drug repurposing candidates.
Despite COVID-19 uncertainties, Badger Meter (BMI) witnesses solid third-quarter 2020 results with major rise in both top and bottom lines on the back of consistent demand across most end markets.
Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.